News Releases

The following news releases are issued by GlaxoSmithKline Inc. In addition to these resources, you may also find GlaxoSmithKline global news of interest.

December 23, 2005

For fifth consecutive year, GlaxoSmithKline recognized as one of the 50 Best Employers in Canada -- For the fifth year in a row, GlaxoSmithKline Inc. (GSK) has been named one of the 50 Best Employers in Canada in the annual list published by The Globe and Mail's Report on Business Magazine.

December 08, 2005

GlaxoSmithKline Acquires Influenza Vaccine Manufacturer ID Biomedical Corporation -- Mississauga, Canada - GlaxoSmithKline plc (NYSE:GSK) today announced the completion of the acquisition of ID Biomedical.

November 15, 2005

Paul Lucas: new chaiman of RX&D'S board of directors -- Canada's Research-Based Pharmaceutical Companies (Rx&D) is pleased to announce the appointment of Paul Lucas, President and Chief Executive Officer (CEO) of GlaxoSmithKline Inc., as Chairman of the Board of Directors.

September 29, 2005

GlaxoSmithKline, with Premier Dalton McGuinty, Announces Manufacturing Expansion, Job Creation and Innovation Investment -- GlaxoSmithKline Inc. President and CEO Paul Lucas will be joined later today by The Honourable Dalton McGuinty, Premier of Ontario and Minister of Research and Innovation

September 20, 2005

Canadian Diabetes Study: A Wake-up Call -- Data from the largest diabetes study of its kind in Canada show that one in two people with type 2 diabetes does not have their blood sugar under control

September 14, 2005

New Research Chair at University of Ottawa to Advance Understanding of Neurological and Psychiatric Disorders -- Leading Health Research Organizations Partner to Fund $2 million Dr. J. David Grimes Research Chair

September 07, 2005

GlaxoSmithKline to Acquire ID Biomedical Corporation

June 03, 2005

New GSK Professorship in Inflammatory Lung Disease Established at University of Calgary -- The University of Calgary and GlaxoSmithKline Partner to Advance Vital Research in the Area of Chronic Lung Disease

June 02, 2005

New GSK Chair in Airway Inflammation Established at University of Alberta -- GlaxoSmithKline Responds to Need for Continued Research and Understanding of Respiratory Illness with $1 Million Endowment

January 26, 2005

$5 Million Respiratory Research Funding for Firestone Institute Already Breathing Success -- GlaxoSmithKline's Five-year Research Funding Commitment Helps Drive Understanding and Treatment of Respiratory Disease.

January 03, 2005

GlaxoSmithKline Named One of Canada's 50 Best Employers for Fourth Straight Year

October 15, 2004

Patients in Year-Long International Asthma Study Able to Live Virtually Symptom Free

October 14, 2004

GlaxoSmithKline named recipient of 2004 Belleau-Nickerson Award for the first AIDS drug, Retrovir®

October 07, 2004

What can you do in 10 minutes? -- New Levitra® Study the first to show an oral erectile dysfunction treatment working in as early as 10 minutes

October 01, 2004

GlaxoSmithKline Foundation Receives Hospice Palliative Care Leadership Award

September 22, 2004

Imitrex DFT - Aims to Deliver What Patients Want Most: Speed to Zero Pain

June 18, 2004

GSK Announces Major Advance In On-line Access To Clinical Trial Information

March 22, 2004

Newly-approved LevitraTM Provides A Satisfying Sexual Experience -- ~ The Erectile Dysfunction Market "Heats Up" ~

March 04, 2004

Study Demonstrates Hycamtin® - Cisplatin Regimen Improves Survival in Advanced Cervical Cancer -- No Additional "Cost" to Patients' Quality of Life with Combo Therapy

February 17, 2004

First anti-viral proven to reduce the risk of transmission of a sexually transmitted disease approved in Canada -- Health Canada Approves Valtrex® Caplets for Reducing Risk of Spreading Genital Herpes to Uninfected Sexual Partners

February 04, 2004

Chronic Disease Sufferers Find Navigating The Health-Care System More Daunting Than The Disease Itself, Says New Poll -- First program of its kind launched in Ontario to enable more coordinated care

January 06, 2004

New Depression and Anxiety Disorder Medication Helps Address Treatment Drop-out Rate -- Stopping Antidepressant Therapy Prematurely a Widespread Problem

January 01, 2004

Results of pivotal study with Valtrex published in New England Journal of Medicine -- First Anti-Viral Proven to Reduce Transmission of a Sexually Transmitted Disease

November 12, 2003

Product Recall Notice -- Important Information for Asthma and Chronic Obstructive Pulmonary Disease (COPD) Patients

June 24, 2003

LevitraTM DATA at the CUA Meeting demonstrate improved satisfaction in overall sexual performance -- New Clinical Data Reports on the Safety, Efficacy and Sexual Satisfaction Among Men with Erectile Dysfunction

June 19, 2003

AvandametTM FIRST combined medication for type 2 diabetes approved by Health canada

June 16, 2003

VarilrixTM Chickenpox Vaccine Now Available -- Option Offers Broadest Indication to Help Protect Canadian Children Against Varicella

May 29, 2003

Corixa And Glaxosmithkline Enter Into License And Supply Agreement For BexxarTM Therapy In Canada

May 22, 2003

Cold Sore Sufferers Are Tight-Lipped When It Comes To Kissing -- Bothersome blisters stop 54 per cent of sufferers from kissing loved ones

May 08, 2003

New Treatment Option Approved For Chronic Obstructive Pulmonary Disease -- Experts say Advair® is a valuable new option for treating this life-threatening and disabling lung disease

April 07, 2003

Key Partners In Heath Care Rally Around PRIISME - Diabetes -- Tackling the threat of Diabetes in Quebec

April 03, 2003

UK-Canadian Consortium Commits $95 Million To The Largest International Health Research Project Ever Funded In Canada -- Research looks to unravel mysteries of over 350 proteins and lead to new products for unmet medical needs

March 21, 2003

GlaxoSmithKline Welcomes Competition Bureau Decision

January 10, 2003

GSK Media Statement on Internet Export Pharmacies

December 27, 2002

GlaxoSmithKline Recognized as One of 50 Best Companies to Work For in Canada

October 24, 2002

GlaxoSmithKline - A 100 Year Legacy Fact Sheet

Commitment to Asthma Fact Sheet

GlaxoSmithKline Celebrates 100th Anniversary with $2 Million Community Investment To Improve Asthma Care

September 30, 2002

Landmark Study Shows Suppressive Antiviral Therapy with Valtrex® (valacyclovir HCl) Caplets Reduced Sexual Transmission of Genital Herpes -- 118 Canadian Couples at Six Centres Participate in Study

September 23, 2002

Canadian-Led International Studies Show Men Treated with LevitraTM Report Reliable Improvement in Erectile Function Over Time and Improvements in Erection Quality Following Prostate Cancer Surgery -- Canadian Lead Investigators Available for Interviews

September 23, 2002

Bayer and GlaxoSmithKline Announce "LevitraTM" as Global Trade Name for New Investigational Erectile Dysfunction Treatment

June 24, 2002

New Study Shows Migraine Often Mistaken For Sinus Headaches -- Findings Presented at the 44th Annual Scientific Meeting of the American Headache Society

June 20, 2002

New Data Suggest Potential Long-Term Efficacy Of Avandia® -- Improvements in Blood Sugar Control Achieved in Patients Receiving Treatment with Avandia as Monotherapy or in Combination Therapy

June 18, 2002

One Million Dollar Contribution Will Establish First Ever Research Chair In Pediatric Asthma

May 30, 2002

Patients with Severe Congestive Heart Failure (CHF) Offered New Hope -- Coreg® is now approved to treat severe CHF

May 15, 2002

First And Only Medication For Patients Suffering From Posttraumatic Stress Disorder Receives Approval -- Paxil® approved in Canada for crippling psychiatric disorder

May 08, 2002

Canada's First Guide For Caregivers Providing End-Of-Life Care Launched Today

May 07, 2002

World Asthma Day

April 29, 2002

Canadians Provide 'Prescriptions' For Country's Health Care System

April 16, 2002

Important New Study Shows Requip® Slows The Loss Of Dopamine Function In Parkinson's Disease

November 06, 2001

TrizivirTM Approved by Health Canada -- First To Combine Three HIV Medications in One Tablet

October 03, 2001

Newly Approved Treatment to Provide Relief to Canadians Suffering from Generalized Anxiety Disorder

April 30, 2001

LA breath of fresh air for asthma patients served by the Seigneuries and Longueuil-Est CLSCs and the Centre hospitalier Pierre-Boucher